Search PubMedSearch

PubMed · 2077258

[Tuberculosis sequelae].

Abstract

Although pulmonary tuberculosis decreased remarkably by antituberculous chemotherapy, we have had a lot of patients associated with sequelae who need medical treatment for many symptoms several or dozens years later. Moreover, in these days the delayed detection of pulmonary tuberculosis that is still an important problem may cause new sequelae. However, we have not had the clear definition of tuberculosis sequelae. Then I would like to definite the tuberculosis sequelae as follow. In a narrow sense, the sequelae is a pathological status that is caused by many patho-anatomical change in the healing process of pulmonary tuberculosis and need clinical treatment for many symptoms. The pulmonary tuberculosis sequelae include secondary infection such as aspergillosis, atypical mycobacteriosis and bacterial airway infection. In a broad sense, the sequelae also represent a pathological status with many symptoms after treatment that is caused by injuries in various organs with tuberculosis. I pointed out the problems of sequelae at this conference sixteen years ago. These problems may be beyond the category of tuberculosis study, but are extremely important for chest physicians.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Yoneda. 1990. [Tuberculosis sequelae].. https://pubmed.ncbi.nlm.nih.gov/2077258/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Systemic mycoses. Epidemiology, clinical aspects, diagnosis].

Systemic mycoses are serious, often life-threatening, infections that are encountered with increasing frequency in many countries. These infections are most often seen as a result of advanced medical treatment leading to profoundly immuno-suppressed patients. In Norway, most systemic mycoses are caused by Candida, followed by Aspergillus, Cryptococci and Mucorales. This paper deals with the pathogenetic and immunologic mechanisms underlying these infections. The different agents are described, and the various clinical manifestations. A discussion of the diagnosis of systemic mycoses is followed by some general considerations regarding treatment.

Aspergillosis